Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Supriya Lifescience Ltd.
₹705
Invest in SUPRIYA with up to 2.22x margin.
Trade with MTF₹698.85
₹711.80
₹545.50
₹832.40
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 206.44 | 199.83 | 145.07 | 184.11 | 185.65 |
| Operating Expense | 134.36 | 127.19 | 93.37 | 116.52 | 119.70 |
| Operating Profit | 72.08 | 72.65 | 51.70 | 67.58 | 65.95 |
| Depreciation | 6.82 | 6.64 | 6.45 | 6.08 | 4.96 |
| Interest | 0.49 | 0.42 | 0.51 | 0.42 | 0.51 |
| Tax | 17.24 | 17.89 | 12.62 | 13.68 | 15.80 |
| Net Profit | 49.68 | 50.43 | 34.79 | 50.38 | 46.78 |
Research Type
Equity , Long Term
Buy Range
₹640 - ₹651
Target Price
₹782
Stop Loss
-
Target Date
26 Apr 27
Potential Returns
22.19 %
₹705.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 |
| FII | 6.5 | 7.2 | 6.8 | 5.5 | 5.2 | 5.2 |
| DII | 4.9 | 4.2 | 4.8 | 5.2 | 5 | 5.7 |
| Public | 20.2 | 20.2 | 20.1 | 21 | 21.5 | 20.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 63.26 K | 1.32 L | 47.99% |
| Week | 70.8 K | 1.6 L | 44.36% |
| 1 Month | 1.2 L | 2.43 L | 49.33% |
| 6 Month | 97.81 K | 1.94 L | 50.54% |
Companies with no Debt
Benjamin Graham Value Screen
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2025 | 1 | FINAL | 05 Sep, 2025 | Equity Share |
| 20 Sep, 2024 | 0.8 | FINAL | Equity Share | |
| 15 Sep, 2023 | 0.6 | FINAL | Equity Share | |
| 01 Sep, 2022 | 0.6 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,685.20 | ₹660 | ₹950 | ₹4,775 | ₹558.05 | ₹1,389.70 |
| % Change | -3.31% | -1.83% | -0.14% | 0.30% | 1.83% | 0.47% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹935 | ₹4,256.70 | ₹3,078.16 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹257.90 | ₹318.19 | ₹431.74 |
| PE TTM | - | - | 76.50 | 42.60 | 27.60 | 44.50 |
| 1 Year Return | 61.23 | 10.96 | 97.07 | -3.76 | 8.77 | -5.51 |
| ROCE | 30.24 | 34.78 | 34.76 | - | 11.27 | 12.74 |
Cohance Lifesciences Ltd.
₹ 487.90
+0.63%
Jubilant Pharmova Ltd.
₹ 1009.00
+2.84%
Granules India Ltd.
₹ 750.10
+0.89%
Concord Biotech Ltd.
₹ 1170.00
-2.39%
Caplin Point Laboratories Ltd.
₹ 1854.00
-0.68%
Marksans Pharma Ltd.
₹ 197.50
-2.72%
FDC Ltd.
₹ 380.25
+1.25%
Sun Pharma Advanced Research Company Ltd.
₹ 173.01
+3.69%
Syngene International Ltd.
₹ 459.50
-1.68%
Blue Jet Healthcare Ltd
₹ 491.00
+0.13%
Sanofi India Ltd.
₹ 3332.90
-1.70%
Alembic Pharmaceuticals Ltd.
₹ 783.00
+0.83%
Procter & Gamble Health Ltd.
₹ 5368.00
+0.89%
Shilpa Medicare Ltd.
₹ 434.00
-1.74%
Jeena Sikho Lifecare Ltd.
₹ 748.00
+1.29%
Aarti Pharmalabs Ltd.
₹ 767.00
-1.37%
Strides Pharma Science Ltd.
₹ 1169.00
+1.94%
Alivus Life Sciences Ltd.
₹ 1120.10
-0.09%
By signing up I certify terms, conditions & privacy policy